Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Various Ropivacaine Concentrations on Ankle Block for Hallux Valgus Surgery
2024-510569-41-00Phase 4Authorised
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in bunion deformity (HAV) (3 arms), sponsored by Ziekenhuis Oost-Limburg. Primary endpoint: Duration of sensory block. Planned start Apr 2024; status: authorised.
02
Drugs
ropivacaine
03
Conditions
bunion deformity (HAV)
Beyond the preview
Go deeper on 2024-510569-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510569-41-00.